CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.
You will lead the implementation, evaluation and continual processes improvement initiatives for R&D.
Key Responsibilities
Identify/ Implement value add, cost saving, productivity initiatives to maximize R&D investment: where appropriate, provide project leadership for such initiatives (matrix teams and FSP as needed)
Champion and lead continuous improvement initiatives
Form and lead ad hoc or standing cross-R&D business issues resolution team, Business Partners Networks etc to deliver the strategic initiatives selected by RDLT (matrix organization and FSP)
Primary support for cross R&D business related issues
Oversee audit implementation, analysis and follow-up
Skills and Experience Required
12+ years in R&D operations, business support
Strong coordination skills with enabling functions and matrix teams
Experience working in cross-functional R&D teams and leading major initiatives
Requires strong business acumen
Requires experience in data driven process improvement initiatives
Established and credible strength in project management
In-depth knowledge in drug research, development and manufacturing processes of pharmaceuticals
Strong communication skills (written, verbal, presentation) in English; experience adapting messaging to suit the intended audiences
Excellent strategic thinking skills
Qualifications and Education Required
Bachelor’s or Master’s in science, operations, or business-related field
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL